Acid inhibitory characteristics of omeprazole in man
- 1 January 1985
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 20 (sup108), 105-112
- https://doi.org/10.3109/00365528509095823
Abstract
Single-dose studies in man have shown that omeprazole is a potent inhibitor of acid secretion stimulated by betazole, pentagastrin, modified sham-feeding and peptone. The degree of inhibition is dose-dependent and correlates to the area under the plasma omeprazole concentration-time curve. The duration of action of a single oral dose is 2-3 days and not dependent on a sustained plasma concentration of omeprazole. During repeated once-daily administration the level of acid inhibition increases over the first 5 days, after which it stabilizes. With once-daily omeprazole treatment it is possible to almost abolish 24-h intragastric acidity in the majority of duodenal ulcer patients.This publication has 11 references indexed in Scilit:
- Effect of Oral Omeprazole on Serum Gastrin and Serum Pepsinogen I LevelsGastroenterology, 1984
- Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity.Gut, 1984
- Action of omeprazole (a benzimidazole derivative) on secretory responses to sham feeding and pentagastrin and upon serum gastrin and pancreatic polypeptide in duodenal ulcer patients.Gut, 1984
- Dose-Response Study of Omeprazole on Meal-Stimulated Gastric Acid Secretion and Gastrin ReleaseGastroenterology, 1983
- Inhibition of gastric acid secretion by omeprazole in the dog and ratGastroenterology, 1983
- Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man.Gut, 1983